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ttp://dx.doi.org/10.1016/j.ajpath.2015.01.031Collagen V mutations underlie classic Ehlers-Danlos syndrome, and joint hypermobility is an important
clinical manifestation. We deﬁne the function of collagen V in tendons and ligaments, as well as the
role of alterations in collagen V expression in the pathobiology in classic Ehlers-Danlos syndrome. A
conditional Col5a1ﬂox/ﬂox mouse model was bred with Scleraxis-Cre mice to create a targeted tendon and
ligament Col5a1-null mouse model, Col5a1Dten/Dten. Targeting was speciﬁc, resulting in collagen Venull
tendons and ligaments. Col5a1Dten/Dten mice demonstrated decreased body size, grip weakness,
abnormal gait, joint laxity, and early-onset osteoarthritis. These gross changes were associated with
abnormal ﬁber organization, as well as altered collagen ﬁbril structure with increased ﬁbril diameters
and decreased ﬁbril number that was more severe in a major joint stabilizing ligament, the anterior
cruciate ligament (ACL), than in the ﬂexor digitorum longus tendon. The ACL also had a higher collagen
V content than did the ﬂexor digitorum longus tendon. The collagen Venull ACL and ﬂexor digitorum
longus tendon both had signiﬁcant alterations in mechanical properties, with ACL exhibiting more
severe changes. The data demonstrate critical differential regulatory roles for collagen V in tendon and
ligament structure and function and suggest that collagen V regulatory dysfunction is associated with
an abnormal joint phenotype, similar to the hypermobility phenotype in classic Ehlers-Danlos syndrome.
(Am J Pathol 2015, 185: 1436e1447; http://dx.doi.org/10.1016/j.ajpath.2015.01.031)Supported by NIH/National Institute of Arthritis and Musculoskeletal
and Skin Diseases grants AR044745 (D.E.B.) and AR065995 (L.J.S. and
D.E.B.).
Disclosures: None declared.Ehlers-Danlos syndrome (EDS) is a hereditary connective
tissue disorder characterized by joint hypermobility, skin
extensibility, and connective tissue fragility.1e5 The com-
bined prevalence of all types of EDS is approximately 1 in
5000. More than half of these cases are characterized by joint
hypermobility,6 and hypermobility is one of the major diag-
nostic criteria for the classic subtype of EDS. Joint hyper-
mobility can cause chronic joint and limb pain, recurring joint
dislocation, and sports injuries with potential degenerative
complications, including muscle weakness, precocious oste-
oarthritis, spondylosis, and lower bone mass.6e9
In more than 90% of patients with classic EDS, collagen
V mutations have been identiﬁed,3,10 and approximately
half are null-allele mutations resulting in COL5A1 hap-
loinsufﬁciency.10e12 Besides the null-allele mutations, mu-
tations scattered throughout COL5A1 and COL5A2 genesstigative Pathology.
.and some mRNA splicing mutations in COL5A1 also have
been identiﬁed.10 This ﬁnding has led to the proposal that
classic EDS is a collagen V disease resulting from altered
collagen V expression.10
Collagen V is a quantitatively minor, regulatory component
in collagen Ierich connective tissues, including dermis, ten-
dons and ligaments, bones, blood vessels, and cornea.13
Collagen V content relative to collagen I varies from a high
of 10% to 20% in cornea to 2% to 5%of the total ﬁbril-forming
collagens in most other tissues.14,15 Collagen V regulates
collagenﬁbrillogenesis by nucleatingﬁbril assembly in in vitro
Targeted Collagen V Deletion in Miceself-assembly assays, cell culture analyses, and mouse mod-
els.14,16e19 The data support a model whereby the collagen V:I
ratio in different tissues determines the initial diameter and
number of ﬁbrils assembled. By varying the number of
collagenVnucleation sites for a given collagen I concentration,
the ﬁbroblast can regulate ﬁbril number and diameter in a
tissue-speciﬁc manner, ie, more sites result in increased ﬁbrils
assembled with smaller diameters.13,17
Several mouse models have been established to elucidate
the function of collagen V tissue-speciﬁc ﬁbril assembly.
A traditional homozygous deletion in the Col5a1 gene is
embryonic lethal because of a virtual lack of ﬁbril formation
at the beginning of organogenesis in the early embryo,
although the Col5a1/mice synthesize and secrete collagen
I at a level comparable with that of wild-type controls.18 This
model demonstrates that collagen V is essential for the
assembly of collagen Iecontaining ﬁbrils in the low-collagen-
concentration environment of the embryo and is consistent
with a critical role in nucleation of ﬁbril assembly. The het-
erozygous Col5a1þ/ mice demonstrate haploinsufﬁciency,
with approximately 50% of wild-type collagen V expression.
Col5a1þ/ mice are excellent models of classic EDS.20 There
were two subpopulations of ﬁbrils in the mutant dermis. One
had increased diameters and normal ﬁbril structure, and these
were immunoreactive for collagen V; the second group had
very large diameters with aberrant ﬁbril structure and were
negative for collagen V reactivity. This suggests relatively
normal assembly when nucleated with collagen, but the
expression level of collagen V was insufﬁcient to nucleate all
available collagen I and, therefore, dysfunctional ﬁbril assem-
bly in the high-collagen-content environment. This abnormal
ﬁbril growth recapitulated that seen clinically in the dermis of
EDS patients. In addition, the Col5a1þ/ ﬂexor digitorum
longus tendon (FDL) also demonstrates decreased cross-
sectional area and stiffness compared with that in the wild-
type controls,21 consistent with the joint hypermobility and
dislocations seen in EDS patients.
To overcome the embryonic lethal phenotype and permit
analyses of the roles of collagen V in the development and
maturation of a tissue-speciﬁc extracellular matrix, our
group created a conditional collagen Venull mouse model
by using a Cre/loxP approach.22 When targeted to the
corneal stroma, a severe dysfunctional regulation of ﬁbril-
logenesis and corneal opacity was observed in the targeted
collagen Venull mice. Unlike cornea, the tendon has a low
collagen V content. The mature tendon contains uniaxial
ﬁbrils with a very heterogeneous population of ﬁbril dia-
meters, and the mechanical properties of the tendon depend
on the increases in ﬁbril diameter seen with development.23
Our aimwas to explore speciﬁc regulatory roles for collagen
V in tendons and ligaments, as well as its roles in the patho-
physiology associated with joint hypermobility in classic
EDS. Our conditional Col5a1ﬂox/ﬂox mouse model was tar-
geted to tendons and ligaments usingCre driven by a Scleraxis
(Scx) promoter (Scx-Cre) to produce the Col5a1Dten/Dten
mouse model. Scx-Cre targets the deletion to tendons andThe American Journal of Pathology - ajp.amjpathol.orgligaments. Thedata demonstrate that the absenceof collagenV
results in a disruption in tendon and ligament structure and
function. In addition, there were consistent differences be-
tween the FDL tendon and the anterior cruciate ligament
(ACL), indicating tissue-speciﬁc regulatory properties. The
absence of collagen V also resulted in alterations in the joint
consistent with the hypermobility seen in classic EDS.
Materials and Methods
Generation of Tendon- and Ligament-Speciﬁc
Col5a1Dten/Dten Mice
Conditional Col5a1ﬂox/ﬂox mice were created by ﬂanking
exons 3 and 4 of the Col5a1 gene with loxP elements and
have been described previously.22 Scx-Cre transgenic
mice express Cre driven by the Scx promoter, thereby
targeting expression to tendons and ligaments.24 Tendon-
and ligament- speciﬁc expression was characterized by
breeding Scx-Cre mice with Cre reporter mTmG (membrane-
Tomato/membrane-Green) mice (The Jackson Laboratory, Bar
Harbor, ME). To generate tendon- and ligament-speciﬁc
collagen Venull mice, we crossbred Scx-Cre transgenic
mice with conditional Col5a1ﬂox/ﬂox mice for two generations
to create Scx-Creþ/Col5a1ﬂox/ﬂox (Col5a1Dten/Dten) mice. The
primers for the genotyping and characterization of
Col5a1Dten/Dten mice were described previously.22 All
animal studies were performed in compliance with animal
protocols approved by the Institutional Animal Care and
Use Committee.
Immunoblotting
FDL tendons, ACL, skin, bone, and cornea were dissected
from postnatal day (P)10 male mice. Protein extracts were
prepared in 50 mmol/L Tris-HCl, pH 6.8, 1% SDS lysis
buffer with proteinase inhibitors (Thermal Scientiﬁc, Wal-
tham, MA). Protein lysates (20 mg) were separated on a 4%
to 12% Bis-Tris gel (Life Technologies, Grand Island, NY)
and transferred onto a Hybond-C membrane (GE Health-
care, Pittsburgh, PA). The membrane was hybridized with
afﬁnity puriﬁed anti-a1(V),18 and anti-b-actin antibodies
(Millipore, Billerica, MA). To analyze collagen V expres-
sion in FDLs and ACLs from wild-type C57BL/6 mice, we
dissected control Col5a1ﬂox/ﬂox mice and Col5a1Dten/Dten
mice, and the same procedures were followed.
Real-Time PCR
FDLs and ACLs were dissected from the mice at P10 and
were cut into small pieces. Total RNA from FDL was
extracted using the RNeasy Micro Kit (Qiagen, German-
town, MD). Total RNA (3 ng per well) was subjected to
reverse transcription by using the High-Capacity cDNA
Reverse Transcription Kit (Life Technologies), and real-
time PCR was performed with SYBR Green PCR master1437
Sun et almix (Life Technologies) on a StepOnePlus Real-Time PCR
System (Life Technologies). The primer sequences were as
follows: Col5a1: forward, 50-AAGCGTGGGAAACTGC-
TCTCCTAT-30, and reverse, 50-AGCAGTTGTAGGTGA-
CGTTCTGGT-30; b-actin, forward, 50-AGATGACCCAG-
ATCATGTTTGAGA-30, and reverse, 50-CACAGCCTGGA-
TGGCTACGT-30. Each sample was run in triplicate, and data
were analyzed using StepOne software version 2.0 (Life
Technologies, Foster City, CA). b-Actin was used as an in-
ternal control to standardize the amount of sample total RNA.
Immunolocalization
FDL tendons were dissected from control Col5a1ﬂox/ﬂox
mice and Col5a1Dten/Dten mice at P4 and P30 and were ﬁxed
in the ﬁxative containing 4% paraformaldehyde, embedded
in an OCT compound and frozen at 80C. Cross sections
(5 mm) were cut using an HM 505E cryostat (Thermo Fisher
Scientiﬁc). For the ACLs, whole knee joints were removed
from littermate control and knockout mice at P4, skinned,
and trimmed of extra muscles. Sagittal sections (5 mm)
containing longitudinal ACL were cut. Immunolocalization
was performed using immunoﬂuorescence microscopy to
analyze expression of collagen V. Before the incubation
with antibodies, the sections were pretreated with testicular
hyaluronidase to enhance penetration. Anti-mouse collagen
V antibody was used at 1:400. The secondary antibody was
goat anti-rabbit IgG Alexa Fluor 568 (Life Technologies) at
1:400. Vectashield mounting solution with DAPI (Vector
Laboratories, Burlingame, CA) was used as a nuclear
marker. Images were captured using a CTR 5500 ﬂuores-
cence microscope (Leica, Wetzlar, Germany) and DFC 340
FX digital camera (Leica). Antibody incubations and image
acquisition were performed concurrently for sections of
control Col5a1ﬂox/ﬂox and Col5a1Dten/Dten mice by using
identical procedures and settings to facilitate comparison.
Gait Analysis
Footprints were recorded for gait analysis of individual
mice. Hind limbs of the mouse were dipped in nontoxic
paint, and the mouse was allowed to walk freely on a piece
of white paper in a walkway consisting of two Plexiglas
walls, spaced 8 cm apart. The footprint recording was
repeated at least three times for each mouse. Parameters for
stride length, intermediate toe spread, and total toe spread
were calculated from walking tracks recorded on the paper.
Stride length was the distance between adjacent prints made
by the same hind limb.
Grip Strength
To assess musculoskeletal and motor function impairment
of the conditional knockout mouse, we used a grip strength
meter (San Diego Instruments, San Diego, CA) to record the
peak force the animal exerted in grasping a grip placed at1438the forelimb. The grip strength meter was positioned hori-
zontally, and the mouse was held by the tail and lowered
toward the grip strength platform. The animal was allowed
to grasp the forelimb grip with its forepaws. The mouse then
was pulled steadily by the tail away from the rod until the
mouse’s grip was broken. The force applied to the grip just
before the animal lost its grip was recorded as the peak
tension. Ten measurements from each mouse were recorded,
and the mean force was used to represent the grip strength
for each mouse.
Biomechanics
Postnatal day 60 (P60) FDLs were analyzed as previously
described25 by using eight wild-type control mice and eight
Col5a1Dten/Dten mice. Brieﬂy, cross-sectional areas of the
P60 tendons were measured using a custom laser-based
device.26 P60 tendons were clamped in custom test ﬁx-
tures, and standard mechanical testing protocols were used
as described. Student’s t-tests were performed on cross-
sectional area, stiffness, and elastic modulus comparing
across genotype (signiﬁcance at P < 0.05).
ACLs were analyzed using 19 control and 10 Col5a1Dten/
Dtenmale mice at age P60. Brieﬂy, hind limbs were obtained,
and the ACL was dissected free of soft tissue, leaving only
the tibia-ACL-femur complex intact, and Verhoeff stain was
applied for optical strain tracking.27 The femur and tibia were
afﬁxed in custom-built testing ﬁxtures such that the femur
was vertical and the tibia was at approximately 60 degrees of
ﬂexion. The ACLwas tested using a standard testing protocol
as described for the FDL but adjusted for a 1-mm gauge
length for the ACL. Cross-sectional area was calculated
assuming an ellipsoidal shape, with length and width
measured in the coronal and sagittal planes. Local strain was
measured optically, and parameters, ie, modulus and stiff-
ness, were calculated using custom Matlab software version
2012a (Mathworks, Natick, MA). Modulus is the slope of the
linear portion of the stress-versus-strain curve, where stress is
the force divided by cross-sectional area and strain is the
change in length divided by the initial length. Stiffness is a
structural parameter that can vary with tissue size, but
modulus is a property of the material. Maximum stress was
calculated as maximum load divided by initial area. Com-
parisons were made between groups by using Student’s t-
tests with signiﬁcance set at P < 0.05.
Transmission Electron Microscopy
FDLs andACLs fromCol5a1Dten/Dten and controlCol5a1ﬂox/ﬂox
mice at ages P4 and P30 were used for ultrastructural analysis.
The samples were prepared for transmission electron micro-
scopy as previously described.25 Sections were examined and
photographed at 80 kV by using a JEM-1400 transmission
electron microscope (JEOL USA, Peabody, MA) and a Gatan
Orius wideﬁeld side mount digital camera (Gatan, Warren-
dale, PA).ajp.amjpathol.org - The American Journal of Pathology
Figure 1 Targeted deletion of collagen V in ﬂexor digitorum longus (FDL)
tendons.A: Cre excisionwas targeted to tendons by using a Scleraxis promoter
(Scx-Cre) in a double reporter (mTmG) mouse. Analysis of cross sections from
postnatal day 4 (P4) limbs shows ubiquitous expression of red ﬂuorescence
(mT) in control mTmG mice. In contrast, Scx-Cre/mTmG mice show green
ﬂuorescence (mG) in the tendon, indicating targeted Cre excision. Other tis-
sues show no Cre recombinase activity. DAPI (blue), nuclear localization. B:
Col5a1 mRNA expression in the postnatal day 10 Col5a1Dten/Dten FDL is at
background levels at real-time PCR. In contrast, expression in Col5a1ﬂox/ﬂox
(Col5a1f/f) control mice is comparable with that in the wild-type mice. C:
Postnatal day 10 FDLs are collagen V null in Col5a1Dten/Dtenmice. Immunoblot
analysis using antibodies against the alpha 1 chain of collagen V [a1(V)] and
against b-actin as a loading control. Control Col5a1ﬂox/ﬂox and wild-type mice
express comparable collagen V. D: Collagen V immunoreactivity (red) is pre-
sent in postnatal day 30 control (Ctrl) FDLs but absent in Col5a1Dten/Dtenmice.
DAPI (blue), nuclear localization. Scale barsZ 20 mm (A).
Targeted Collagen V Deletion in MiceFibril Diameter Measurement
Fibril diameter was analyzed as previously described.21,28
Collagen ﬁbril diameters in FDLs and ACLs from three
different P30 mice from each genotype were analyzed. Four
nonoverlapping cross-sectioned digital images were obtained
at 60,000 from the central areas of each specimen. Di-
ameters were measured along the minor axis of cross sections
by using an RM Biometrics-Bioquant Image Analysis Sys-
tem (Nashville, TN). Data analysis and histograms were
created using Microsoft Excel 2007 (Redmond, WA). Fibril
density was obtained as the ﬁbril number per unit area.
Histologic Analysis
Col5a1Dten/Dten mice and Col5a1ﬂox/ﬂox control mice at P4
and P30 were whole-body perfused with 4% paraformal-
dehyde. Intact knee joints were dissected, decalciﬁed, and
embedded in parafﬁn. Sections (5 mm) were cut in the frontal
plane toward the back or sagittal plane from lateral toward
medial. Sections were collected from the central weight-
bearing region of the tibial plateau on the basis of the
presence of the ACL and anatomy of the lateral meniscus.
Sections were stained with either H&E or Safranin O. His-
tologic images were captured using an Olympus BX61 TRF
microscope and a DP72 12.8-megapixel digital color camera
(Olympus, Center Valley, PA).
Results
Generation of a Tendon- and Ligament-Speciﬁc
Conditional Collagen VeNull Mouse Model
To overcome the embryonic lethal phenotype in the tradi-
tional Col5a1-null mice,18 a mouse line was established with
Col5a1 exons 3 and 4 ﬂanked by loxP elements.22 This
conditional mouse line Col5a1ﬂox/ﬂox was crossed with a Scx-
Cremouse line. The Scx-Cre transgenic mouse line expresses
Cre under the control of the regulatory sequence for the Scx
gene that is expressed in tendon and ligament cells beginning
with progenitor stages.29,30 To determine the tissue speci-
ﬁcity and efﬁcacy of recombination driven by Scx-Cre, we
crossed Scx-Cre mice with a Cre reporter (mTmG) mouse
line.31 The mTmG mouse is a dual-ﬂuorescent Cre reporter
mouse with loxP sites ﬂanking a mT cassette. It expresses
strong red ﬂuorescence in all tissues including skin and
tendon in the absence of Cre expression (Figure 1A). In
contrast, when the mTmG mouse is crossed with an Scx-Cre
mouse, the Cre recombinase in the tenocytes from the
offspring excises the mT cassette and activates the down-
stream membrane-targeted enhanced green ﬂuorescent pro-
tein (mG) cassette that expresses strong green ﬂuorescence.
The Scx-Cre recombinase activity is limited to tendons
(Figure 1A) and ligaments (Figure 2A). The red ﬂuorescence
remained in other tissues, including skin, muscle, and bone
tissues in the limb cross sections from P4 mice (Figure 1A).The American Journal of Pathology - ajp.amjpathol.orgThese data are consistent with a lack of Cre excision in these
tissues and demonstrate speciﬁc tendon and ligament tar-
geting by using the Scx-Cre mouse.
To produce a targeted tendon and ligament collagen
Venull mouse model, we bred Scx-Cre mice with the con-
ditional Col5a1ﬂox/ﬂox mouse line22 that produced Scx-Creþ/
Col5a1ﬂox/þ mice. Intercrossing Scx-Creþ/Col5a1ﬂox/þ mice
with Col5a1ﬂox/ﬂox mice generated mice homozygous for the
ﬂoxed allele expressing Cre under the Scx promoter (Scx-
Cre). The Cre excision of exons 3 and 4 resulted in mice with
Col5a1-null tendons and ligaments (Col5a1Dten/Dten). The
expression of Col5a1 mRNA and collagen V was analyzed in1439
Figure 2 Targeted deletion of collagen V in anterior cruciate ligament
(ACL) driven by Scleraxis-Cre (Scx-Cre). A: Posterior view of the knee joint of
Scx-Cre/mTmGmouse at postnatal day 10 shows the ACL and posterior cruciate
ligament (PCL) with green ﬂuorescent protein expression (left panel). No
green ﬂuorescent protein is expressed in the mTmG control mouse knee joint
(right panel). Arrows indicate the position of the ACL and PCL. The image was
obtained with a ﬂuorescence dissecting microscope. B: Immunoﬂuorescence
microscopy showed the depletion of collagen V expression in the Col5a1Dten/
Dten ACL at postnatal day 10 (right panel) compared to the controls (left
panel). Green, collagen V; red, phalloidin; blue, DAPI stained nucleus. C:
Immunoblotting shows noexpression of collagenV in Col5a1Dten/DtenACLs. The
Col5a1ﬂox/ﬂox (Col5a1f/f)mouseACL expressed the sameamountof collagenVas
did that of wild-type C57BL/6 mice. Ctrl, control; double reporter, mTmG.
Sun et althe Col5a1Dten/Dten mice. In the P10 Col5a1Dten/Dten FDL ten-
dons, Col5a1 mRNA expression was decreased to background
levels compared with that in the wild-type P10 FDL tendons.
Col5a1 mRNA expression in the control Col5a1ﬂox/ﬂox mouse
FDL was comparable with that in wild-type FDL (Figure 1B).
Consistent with the lack of mRNA expression, collagen V was
completely absent in tendons from P10 Col5a1Dten/Dten mice,
whereas the expression in the control Col5a1ﬂox/ﬂox FDL was
comparable with that in wild-type mice (Figure 1C). In the P30
control mouse FDL tendon, collagen V was homogeneously
distributed throughout the ﬁber bundles. In the Col5a1Dten/Dten
FDL, the expression of collagen V was absent (Figure 1D). In
addition, collagen V expression also was not detected in the1440ACLs of Col5a1Dten/Dten mice at immunoﬂuorescence micro-
scopy (Figure 2B), and this ﬁnding was conﬁrmed by using
immunoblot analysis (Figure 2C). These data indicate that the
Col5a1Dten/Dten mouse is a tendon- and ligament-speciﬁc
collagen Venull mouse model line.
Conditional Inactivation of Tendon and Ligament
Col5a1 Gene Expression Results in Abnormal Gait
and Joint Phenotype
Col5a1Dten/Dten mice are viable; however, grossly they are
easily distinguished from their Cre-negative littermates by
the signiﬁcantly smaller body size, slow movement, and
abnormal gait in the young mice and joint dislocation in the
older mice. We could speculate that the decreased body
weight is the result of impaired mobility and function
resulting in sedentary mice with difﬁculty feeding beginning
at birth. In Col5a1Dten/Dten mice, the knee joints were
positioned abnormally (Figure 3A). When the mouse was
lifted gently by the tail, the two feet of the control mouse
were positioned symmetrically, pointed to the front with the
toes spread (Figure 3B). In contrast to the control mice, the
feet of the Col5a1Dten/Dten mouse were not positioned
symmetrically and usually were pointed outward or clutched
together (Figure 3B). At age P60, the Col5a1Dten/Dten mouse
was signiﬁcantly smaller than the control mouse, and the
body weight was 30% less than that of the control litter-
mates (Figure 3C). Inside the cage, the Col5a1Dten/Dten mice
tended to stay in one spot and were reluctant to move
around. When walking freely on a piece of white paper in a
walkway consisting of two Plexiglas walls, Col5a1Dten/Dten
mice demonstrated major hindlimb differences in gait
characteristics compared with that in Col5a1ﬂox/ﬂox mice.
The Col5a1Dten/Dten mice dragged their hind limbs, with the
body weight on the base of the foot. In contrast, the control
mice placed their body weight on their toes and the middle
part of the plantar surface. Compared with the mutant mice,
the control mice had a consistently longer stride length and
wider toe spread (Figure 3E). Col5a1Dten/Dten mice exhibited
a less stable gait pattern than did Col5a1ﬂox/ﬂox mice.
To assess the musculoskeletal and motor function impair-
ment of our mouse models, we measured the forelimb grip
strength. The forelimb grip strength for the Col5a1Dten/Dten
mice was signiﬁcantly decreased compared with that of the
control mice (P < 0.001) (Figure 3D). Because of the
decreased grip strength, mutant mice could not hang on the
cage wires only by their forelimbs. The Col5a1Dten/Dten mice
also showed excessive joint laxity in the knee and ankle joints
(Figure 3F). This increased joint laxity resembled the joint
hypermobility seen in patients with classic EDS.2,5 This
phenotype progressed as the mice aged. The joint laxity led to
instability, easy joint dislocation, and hypermobility. The
majority of P90 and older Col5a1Dten/Dten mice had at least
one joint dislocation in their four limbs. Both sexes of the
Col5a1Dten/Dten mice were fertile. However, pups were pro-
duced and raised to weaning at a low rate; this may have beenajp.amjpathol.org - The American Journal of Pathology
Figure 4 Early-onset osteoarthritis in Col5a1Dten/Dten mice. Represen-
tative histologic sections of tibial condyles in control and Col5a1Dten/Dten
mice at postnatal day 30. Decalciﬁed knee joint embedded in OCT. Frontal
sections of the knee joint were stained with Safranin O and Fast green. A:
The cartilage surface in the control mouse is smooth. B: The lateral surface
of the tibia condyles in Col5a1Dten/Dten knee joint is covered with ﬁbrous
tissue and chronic inﬂammation cells. The cartilage erosion, chondrocyte
death, and proteoglycan depletion indicate the onset of osteoarthritis in
Col5a1Dten/Dten knee joint.
Figure 3 Joint laxity and aberrant gait in Col5a1Dten/Dten mice. A and B:
Col5a1Dten/Dten mice with a targeted deletion of collagen V in tendons and
ligaments show smaller size and deformation of the limbs in representative
8-month-old female mice (arrows indicate joint dislocation). C: Decreased
body weight in Col5a1Dten/Dten mice. Postnatal day 60 male wild-type (nZ
8) and mutant mice (n Z 8) mice were used. D: Forelimb grip strength
measurement from the same group of mice as in C show weakness
of Col5a1Dten/Dten mice relative to control mice. E: Abnormal gait in
Col5a1Dten/Dten mice. Representative hindlimb prints of control and
Col5a1Dten/Dten mice. The control mice walk in a straight line with regular,
even steps and wide toe spread. The Col5a1Dten/Dten mice show short stride
lengths (vertical bars), with small toe spread. F: Col5a1Dten/Dtenmice exhibit
excess joint laxity compared with that in the control mice when the joint is
overextended passively (arrows, ankle joint). ***P < 0.001. Ctrl, control.
Targeted Collagen V Deletion in Micedue to the limited mobility in the adult Col5a1Dten/Dten mice
(data not shown). These data indicate a severe impairment of
tendon and ligament function in the absence of collagen V.
Early-Onset Osteoarthritis in Col5a1Dten/Dten Mice
The development of osteoarthritis was examined in control
and Col5a1Dten/Dten mouse knee joints. Safranin O stains
glycosaminoglycans in cartilage and is used for grading the
development of osteoarthritis.32 In the 1-month-old control
mice, the articular cartilage of the medial and lateral tibial
plateau or the medial and lateral femoral condyle had a
smooth surface, evenly stained with Safranin O (Figure 4A).The American Journal of Pathology - ajp.amjpathol.orgIn the superﬁcial zone of the articular cartilage, one or two
layers of ﬂat cells were arranged tangentially, and round
cells were observed in the middle zone above the tidemark.
In contrast, the Col5a1Dten/Dten mouse knees showed uneven
staining with Safranin O in weight-bearing cartilage regions,
with formation of ﬁbrillations and further degeneration
demonstrated by the presence of an osteophyte in severe
cases (Figure 4B). These data demonstrate osteoarthritic
progression as an indirect outcome of joint hypermobility as
a result of collagen V deﬁciency in tendons and ligaments
stabilizing the joint.
Altered Biomechanical Properties of FDLs in
Col5a1Dten/Dten Mice
Cross-sectional area, stiffness, and modulus were analyzed
(Figure 5). Cross-sectional area showed a signiﬁcant1441
StiffnessCross Sectional Area Modulus 
Ctrl Col5a1
Δten/Δten
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16 *
0
10
20
30
40
50
60
70
80
90 **
0
500
1000
1500
2000
2500
Figure 5 Altered biomechanical properties in
Col5a1Dten/Dten ﬂexor digitorum longus. Cross-
sectional area, stiffness, and modulus were
measured in postnatal day 60 (P60) male ﬂexor
digitorum longus tendons from Col5a1Dten/Dten and
Scx-Cre control mice. The signiﬁcant decrease in
cross-sectional area and stiffness in Col5a1Dten/Dten
FDLs is consistent with the joint laxity phenotype.
The modulus is comparable in both genotypes.
*P < 0.05, **P < 0.01.
Figure 6 Aberrant ﬁber structure and organization in Col5a1Dten/Dten
tendons during early tendon development. A and B: Postnatal day 4 control
(Ctrl) mouse ﬂexor digitorum longus (FDL) contained organized ﬁbers (F) that
are relatively uniform in size. The ﬁbers were present inmicrodomains that were
deﬁned by tenocyte cytoplasmic processes (curved arrows). B and D: Collagen
protoﬁbrils canbe seenduringdeposition (arrowhead).CandD: Col5a1Dten/Dten
mouse FDLs have less-organized ﬁbers (F). In Col5a1Dten/Dten FDLs, there are
fewer ﬁbers than in thewild-type controls. The collagen Venull FDLs have larger
ﬁbers with more heterogeneity in size than in control tendons. In addition, in
the absence of collagen V, theﬁbers are less organized, ie, less regularly packed,
withmore space separating them than in the controls. In addition, the tenocyte
processes (curvedarrows) deﬁning themicrodomains are less organized than in
the controls.
Sun et aldifference between the control and mutant mice, with the
latter being signiﬁcantly smaller (P < 0.01). This is consis-
tent with signiﬁcant difference in body weight in these two
groups of mice. Stiffness also showed a signiﬁcant difference
between the two genotypes, with the Col5a1Dten/Dten tendons
being less stiff (P < 0.05). However, there were no signiﬁ-
cant differences detected in modulus between the groups
(P Z 0.24). These results indicate that the tendons of
Col5a1Dten/Dten mice were smaller and, thus, were less stiff.
The decreased stiffness is consistent with a role in joint laxity
in EDS.
Aberrant Fiber Structure and Organization in Collagen
VeNull FDL Tendons
The regulatory roles of collagen V in the assembly of ﬁber
structure, ie, organization of ﬁbrils into ﬁbers associated with
tendon ﬁbroblasts, was analyzed at P4 during an early stage
of tendon development. In the wild-type mouse FDL, ﬁbers
were organized uniaxially throughout the tendon. The ﬁbers
were relatively uniform in size and were deﬁned by tenocyte
cytoplasmic processes that deﬁned microdomains where
ﬁbrils were organized into ﬁbers. Collagen protoﬁbrils can
be seen in the cytoplasmic processes during deposition
(Figure 6, A and B). In contrast, the Col5a1Dten/Dten tendon
demonstrated less-organized ﬁbers. Fibril organization into
ﬁbers also was disrupted, with fewer, larger ﬁbers that were
less organized than in the wild-type controls. The ﬁbers were
packed less regularly, with more and irregular spaces sepa-
rating them. In addition, the tenocyte processes deﬁning the
microdomains were less organized than in the controls and
were associated with the disruption in ﬁber organization
(Figure 6, C and D).
Fibril assembly also was altered in the Col5a1Dten/Dten
compared with in the wild-type FDL. Fibril diameters were
more heterogeneous in P30 Col5a1Dten/Dten FDLs than in the
wild-type tendons (Figure 7, A and B). In addition, the
mutant ﬁbrils often demonstrated irregular cross-sectional
proﬁles compared with the circular proﬁles seen in control
mice. Analyses of the diameter distributions demonstrated a
broader distribution with a right-hand shoulder representing
larger-diameter ﬁbrils in the Col5a1Dten/Dten than in the
control FDLs (Figure 7C). In addition, a broadening of the1442diameter distribution was observed as an increase in the
median from 119 nm in the control mouse FDL to 129 nm
in the Col5a1Dten/Dten FDL; the interquartile range Q4 to Q3
increased from 82 to 117 nm, and the interquartile range Q3
to Q1 increased from 139 to 168 nm. The ﬁbril diameter
(means  SD) was signiﬁcantly increased from 114  47
nm in the control mouse FDL to 131  64 nm in the
Col5a1Dten/Dten FDL (Figure 7D). The number of ﬁbrils
decreased, with ﬁbril density approximately 30% less than
in control FDLs (Figure 7E). The assembly of fewer andajp.amjpathol.org - The American Journal of Pathology
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Figure 7 Abnormal ﬁbril structure in mature Col5a1Dten/Dten tendons. A
and B: The Col5a1Dten/Dten ﬂexor digitorum longus (FDL) has larger and more
heterogeneous ﬁbrils than do the wild-type controls. In addition, ﬁbrils
assembled in collagen Venull tendons show aberrant structures (arrow). C:
Histograms represent the distribution of ﬁbril diameters in the FDL tendon of
control and Col5a1Dten/Dten mice. The Col5a1Dten/Dten mice have broader dis-
tribution of the ﬁbril diameters, with increased ﬁbril numbers of both small-
diameter and large-diameter ﬁbrils. The diameter was measured in three
different mice of each group, with seven images from each mouse. D: The mean
ﬁbril diameter is increased signiﬁcantly in the FDL of Col5a1Dten/Dten mice. E:
The ﬁbril density is decreased signiﬁcantly in the FDL of Col5a1Dten/Dten mice.
The means  SD, nZ 21, and Student’s t-test (D and E). All FDLs were from
male mice at postnatal day 30. ***P < 0.001. Ctrl, control; Q, quartile.
Targeted Collagen V Deletion in Micelarger-diameter ﬁbrils is consistent with dysregulated ﬁbril
nucleation and assembly in the absence of collagen V.21
Joint laxity and dislocation are the major gross pheno-
types in the Col5a1Dten/Dten mice, consistent with a classic
EDS joint phenotype. The structural and functional data
from the FDL are consistent with a role in joint stability.
Data derived from one tendon or ligament often is gener-
alized to tendons and ligaments, but this ﬂexor tendon does
not function directly to stabilize joints in vivo. Therefore, a
ligament intrinsic to the joint, the ACL, which is a critical
ligament in maintaining knee stability, was analyzed.
Expression of Collagen V Is Higher in ACL than in FDL
Collagen V was analyzed in ACL, FDL, and other con-
nective tissues in wild-type mice at P10. Consistent withThe American Journal of Pathology - ajp.amjpathol.orgother results from reports, collagen V expression in FDL
was very low and in cornea was very abundant, accounting
for 10% to 20% of total collagen.14 Collagen V expression
in ACL was substantially higher than that in the FDL; ACL
expression was comparable with or higher than that in skin
and bone but lower than that in cornea (Figure 8). Col5a1
mRNA expression in P10 mice also indicated higher Col5a1
mRNA expression in the ACL relative to that in the FDL
(data not shown). These data suggested that the different
collagen V expression levels in ACL versus FDL may
contribute to tissue-speciﬁc structure and function in ten-
dons and ligaments.
Altered ACL Fibrillogenesis in Col5a1Dten/Dten Mice
The ACL showed a severe disruption of ﬁbrillogenesis in
Col5a1Dten/Dten mice relative to the control mice at age P30
(Figure 9, A and B). Unlike in FDL tendon, the ﬁbril bundles
in ACL are not aligned in parallel, especially at the distal and
proximal ends. However, the ﬁbril arrangement is in parallel
to the axis, and ﬁbril cross sections were compared only in the
ACL midsubstance. At P30, the ﬁbril diameter distribution
patterns were similar in the control ACLs and FDLs. The
ﬁbril diameters were heterogeneous, with larger and smaller
diameter ﬁbrils interspersed (Figure 9A). However, the ﬁbril
diameters in ACLs were smaller than in FDLs of comparable
age. Diameters (means  SD) were 67  27 nm in the ACL
(Figure 9D) compared with 118  47 nm in the FDL
(Figure 7D) at age P30. Compared with those in control mice,
Col5a1Dten/Dten ACLs had a broader ﬁbril diameter distri-
bution (Figure 9C). The ﬁbril diameter distribution showed a
signiﬁcant shift to the larger ﬁbrils in Col5a1Dten/Dten mice,
with a reduction in small-diameter ﬁbrils in ACLs from
Col5a1Dten/Dten mice. The median diameter of the ﬁbrils was
104 nm, ranging from 23 to 256 nm, and the interquartile
range Q4 to Q3 was 119 nm. In contrast, the median ﬁbril
diameter for the control mice was 64 nm, ranging from 13
to 151 nm, and the interquartile range Q4 to Q3 was 63 nm
(Figure 9C). A statistical analysis demonstrated a signiﬁ-
cant increase in the mean ﬁbril diameter (P < 0.001) in the
ACL of Col5a1Dten/Dten mice compared with that in control
mice (Figure 9D). In addition, the number of ﬁbrils
assembled in the Col5a1Dten/Dten ACLs was reduced
compared with that in controls, with a signiﬁcant decrease
in ﬁbril density (P < 0.001) (Figure 9E). The decrease in
density was associated with an increase in ﬁbril diameter,
as well as an increase in interﬁbril spacing. These data
indicated that collagen V is required for normal ﬁbrillo-
genesis in the ACL ligament.
Severe Reduction in the Biomechanical Properties of
Collagen VeNull ACL
During tissue preparation and biomechanical testing, the
ACLs from Col5a1Dten/Dten mice were very fragile. ACLs
frequentlywere broken before dissecting, and even very small1443
Figure 8 High collagen V content in anterior cruciate ligament (ACL)
versus ﬂexor digitorum longus (FDL). Immunoblot analysis shows different
collagen V expression levels in different tissues of postnatal day 30 wild-
type C57BL/6 mice. Cornea expresses the most collagen V, followed by
ACL, which is comparable with that in the skin but much higher than that in
FDL and bone. b-Actin was used as the protein loading control.
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Figure 9 Abnormal anterior cruciate ligament (ACL) structure in the
Col5a1Dten/Dten mouse. A and B: Transmission electron microscopy shows a
signiﬁcant increase in ﬁbril diameter and aberrant ﬁbril structure in the
Col5a1Dten/Dten ACL. The alterations in the collagen Venull ACL were more
severe. C: Histograms show the broader distribution of ﬁbril diameters in the
ACL of Col5a1Dten/Dten mice compared with that in the control mice. D: The
mean ﬁbril diameter is increased signiﬁcantly in the ACL of Col5a1Dten/Dten
mice ACL. E: The ﬁbril density was decreased signiﬁcantly in Col5a1Dten/Dten
mice. Fibril diameter and density were measured in three different mice of
each group, with three to seven images from each mouse; the data are
presented as means SD, and Student’s t-test was used (CeE). All mice were
postnatal day 30 males. ***P < 0.001. Ctrl, control; Q, quartile.
Sun et alloads during careful preparation of the ACLs for testing
caused some ligaments to fail. This occurred only in the
Col5a1Dten/Dten mice and not in the control mice. The
Col5a1Dten/Dten ACLs demonstrated a signiﬁcantly lower
maximum load and maximum stress compared with that in
wild-type controls (data not shown). In contrast to the FDL,
there was no signiﬁcant difference in cross-sectional area
between Col5a1Dten/Dten and wild-type ACLs. However, the
Col5a1Dten/Dten ACLs had a signiﬁcantly lower stiffness and
modulus compared with those in the controls (P < 0.001)
(Figure 10). In the absence of a change in cross-sectional area,
results support a change in the material properties of the ACL
in the absence of collagen V. The mechanical changes in the
ACL were much more dramatic than the changes in the FDL,
suggesting that collagen V has a greater role in the ACL.
Disruption of Higher-Order Structure in ACLs from
Col5a1Dten/Dten Mice
In wild-type ACLs, running from the anterior intercondylar
region of the proximal tibia to the medial aspect of the
lateral femoral condyle within the intercondylar groove,
well-organized ﬁbril bundles and ﬁbroblasts were aligned
parallel to the stress axis in the ACL midsubstance
(Figure 11A). In contrast, in the knees from Col5a1Dten/Dten
mice, the orientation of ACL ﬁbril bundles was disorganized
and wavy. Patchy inﬁltration of lymphocytes and increased
vasculature also were present around the knee joint, consis-
tent with soft-tissue inﬂammation, suggesting a secondary
defect resulting from ligament injury in the unstable joint
(Figure 11A). Collagen ﬁber organization in the ACL was
analyzed using picrosirius red staining with polarized light
microscopy (Figure 11B). Large bright, orange-red collagen
ﬁbers were arranged in parallel and were well organized in
control mouse ACL. In contrast, small and wavy collagen
ﬁbers were sparse and disorganized in Col5a1Dten/Dtenmouse
ACL, indicating that collagen ﬁbers were smaller and less
organized. In the Col5a1Dten/Dten ACL, it is noteworthy that
there was a consistent difference in crimping when compared
with that in the controls (Figure 11B), which would be
consistent with increased elasticity and joint hypermobility.1444Discussion
The targeted deletion of collagen V in tendons and liga-
ments created a mouse model (Col5a1Dten/Dten) that faith-
fully recapitulates the joint laxity seen clinically in patients
with classic EDS. The joint phenotype is the result of
structural and functional changes in tendons and ligaments,
especially the ACL, that is essential for the stabilization of
the lower limb joint. Tendons and ligaments are multiunit
hierarchical structures that contain collagen molecules,
collagen ﬁbrils, collagen ﬁbers, and fascicles organized
parallel to the geometric axis.33e35 Collagen I accounts for
the majority of the collagen mass, whereas collagen V forms
heterotypic ﬁbrils with collagen I in the matrix of different
tissues to regulate the ﬁbril nucleation and initiation of
ﬁbrillogenesis.18,21,36 The Col5a1/ mouse model was
embryonic lethal because of a virtual lack of ﬁbrilajp.amjpathol.org - The American Journal of Pathology
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Figure 10 Altered biomechanical properties in
anterior cruciate ligament (ACL) of Col5a1Dten/Dten
mice. The biomechanical properties are altered
signiﬁcantly in the absence of collagen V, with a
signiﬁcant decrease in stiffness and modulus in
the Col5a1Dten/Dten ACL compared with that in the
controls (Ctrl). ***P < 0.001.
Figure 11 Targeted depletion of collagen V in tendon and ligament
induces joint instability. A: Joint laxity and chronic ﬁbrous inﬂammation
presented in Col5a1Dten/Dten mice knee joints at postnatal day 4. Sagittal
sections of knee joints from postnatal day 4 mice show that the ﬁbroblasts
and ﬁbers of the anterior cruciate ligament (ACL) align parallel in the ACL
midsubstance in the control (Ctrl) mice. In the Col5a1Dten/Dten ACL, the
ﬁbers were disorganized and wavy. The asterisks show synovial inﬂam-
mation that contained ﬁbrous connective tissue, blood vessels, and chronic
inﬂammatory cells in the Col5a1Dten/Dten ACL. Stain: H&E. B: Polarized light
microscopy in control mice shows large, well-organized ACL ﬁbers. In
contrast, the ﬁbers in Col5a1Dten/Dten ACL are wavy and smaller. The
specimens were the same as in A. Stain: picrosirius red.
Targeted Collagen V Deletion in Miceformation. However, the Col5a1Dten/Dten mice are viable and
fertile. The severe disruption in tendon and ligament structure
and function results in sedentarymicewith impairedmobility.
However, unlike in the Col5a1/mouse model, the tendons
and ligaments of the Col5a1Dten/Dten mice assembled ﬁbrils.
The embryo 10.5 days post coitum has a low-collagen-
concentration environment, and the presence of collagen V
as a nucleator to lower the critical concentration required for
initiation of ﬁbril assembly is essential. In contrast, devel-
oping tendons have a high-collagen-concentration environ-
ment in which ﬁbril assembly can occur in the absence of
collagen V, as is observed with in vitro self-assembly as-
says.17 However, the regulation conferred by heterotypic
collagen I/V interactions is absent, resulting in the dysfunc-
tional ﬁbril and matrix assembly observed.
Altered Fibrillogenesis in Collagen V Mouse Models
Previous work in a Col5a1þ/ haploinsufﬁcient mouse model
demonstrated increased ﬁbril diameters and a subpopulation of
ﬁbrils that were large and structurally aberrant in the dermis,
consistent with the classic EDS skin phenotype.20 However,
tendon structure in the haploinsufﬁcient mouse model did not
showmajor structural changes.21 In contrast, theCol5a1Dten/Dten
mouse model demonstrates major changes in tendon and liga-
mentﬁbril structure, including an increase in ﬁbril diameter and
decrease in ﬁbril density. This structural change is consistent
with the ﬁbril changes in EDS patients.37 This suggests that
collagen V must be present above a speciﬁc concentration for
assembly of normal ﬁbrils, but higher concentrations are
required for structural and functional integrity of the tendon.
Altered Fiber Structure and Organization in Collagen
VeNull Mice
In addition to the changes in the ﬁbril formation, collagen ﬁber
organization also is altered in the Col5a1Dten/Dten tendon.
Col5a1Dten/Dten FDLs have less-organized tenocytes, resulting
in fewer and larger ﬁbers that are disorganized compared with
those in the wild-type controls. This ﬁnding suggests that the
loss of collagen V may alter celleextracellular matrix in-
teractions. Tendon ﬁbroblasts establish a hierarchy of extra-
cellular compartments associated with assembly of ﬁbrils,
ﬁbril bundles, and ﬁbers during development.23,38,39 This hi-
erarchy of microdomains allows control over the extracellularThe American Journal of Pathology - ajp.amjpathol.orgevents in matrix assembly. Results from a recent study indi-
cate that collagen V is localized preferentially on the tenocyte
surface as distinct foci in tendons and in cell culture. This
indicates that collagen V associates with the tenocyte surface,
where it is proposed to function in regulation of collagen as-
sembly and cell-directed ﬁbril deposition.40 Collagen V also is
present in a pericellularecell-associated matrix extract from
developing tenocytes.41 Collagen V binds to extracellular
matrix proteins such as collagens, enzymes, and growth fac-
tors through the a1-N-propeptide and is involved in extra-
cellular matrix homeostasis and bridging function in the cell-
matrix environment.42 Depletion of collagen V in tendon may
destroy the binding of extracellular matrix proteins to the cells
and further affect the tenocyte-directed ﬁbril deposition, ﬁber
formation, and higher-level hierarchical organization. How-
ever, the detailed mechanism is still unclear and requires
further investigation.1445
Sun et alAltered Biomechanical Properties in Col5a1Dten/Dten
Mice
Biomechanical studies of the Col5a1þ/ haploinsufﬁcient20
and Col5a1Dten/Dten FDLs demonstrate decreased cross-
sectional area and stiffness. However, the modulus does
not change signiﬁcantly. From a mechanical perspective, this
ﬁnding suggests that the material is functionally the same
between groups, with differences primarily due to the size of
the tissue. The changes in FDLs are relatively mild when
compared with the severe biomechanical phenotype of the
Col5a1Dten/Dten ACL, with a change in stiffness and modulus
but no change in cross-sectional area compared with those in
the controls. Unlike the FDL data, these data suggest a
change in the material properties of the ACL because of the
alterations in the structural organization. The FDL tendon is
neither a weight-bearing tendon nor a direct joint-stabilizing
tendon. Conversely, the ACL is intrinsic to the joint and
essential for its stabilization, as well as one of the most
vulnerable tendons or ligaments in the body.43 The differ-
ences in mechanical and structural properties in the FDL and
ACL suggest that collagen V is a critical regulator of tendon-
and ligament-speciﬁc properties. To our surprise, compared
with collagen V expression in the FDL, collagen V expres-
sion is substantially higher in the ACL. The collagen V level
in ACL was comparable with or slightly higher than that in
skin and substantially higher than that in FDL and bone,
although it is still lower than that in cornea. This is the ﬁrst
time that the collagen V expression level in ACL has been
reported. It is possible that the higher collagen V expression
in the ACL confers tissue-speciﬁc regulatory properties. The
resulting ACL-speciﬁc ﬁbrillogenesis would yield a matrix
structure with a primary function in joint stabilization.
Mouse Model for Classic EDS
When collagen V is knocked out in Col5a1Dten/Dten tendons
and ligaments, there is a signiﬁcant increase in ﬁbril diameter
and decrease in ﬁbril density. The alterations in collagen
organization and structure inﬂuence the biomechanical prop-
erties. A similar disorganization and dysfunction is found in
the tendons of classic EDS patients bearing a COL5A1 muta-
tion.37 The smaller tendon, reduced stiffness, andmodulus are
consistent with a hypermobile joint phenotype supported by
the loose joint capsule, changes in gait, and changes inwalking
patterns. Col5a1Dten/Dten ligaments are easy to rupture. This
ﬁnding, coupledwith joint laxity and dislocation, could lead to
early-onset osteoarthritis as a secondary effect to joint hyper-
mobility, aswas observed in theCol5a1Dten/Dtenmousemodel.
The joint hypermobility phenotype progressed dramatically
with age. The phenotype in the Col5a1Dten/Dten is more severe
than in EDS patients because Col5a1Dten/Dten tendons and
ligaments are null for collagen V, whereas most EDS patients
harbor COL5A1 mutations in only one allele. However, the
mouse provides a valid model that faithfully recapitulates the
clinical joint phenotype. Male mice were used in this initial1446study to ensure that the studies were controlled appropriately
so that phenotypic differences would be explained only by
gene dosage effects. In future work, it would be of interest to
analyze potential sex differences in the mouse model to
address the fact that female patients present more with classic
EDS than do male patients.
Conclusions
Our results indicate that collagen V plays a critical regulatory
role in the ﬁbrillogenesis of tendons and ligaments. The
deﬁciency of collagen V targeted to tendons and ligaments
impairs normal FDL and ACL function, with differential
tissue-speciﬁc effects. The absence of collagen V results in
altered structure and functional properties, resulting in a se-
vere joint hypermobility phenotype analogous to that
observed in EDS patients. This mouse model provides, for
the ﬁrst time, the ability to target collagen V speciﬁcally in
the musculoskeletal system, resulting in a severe joint
phenotype that faithfully recapitulates the clinical phenotype
observed in classic EDS patients. Therefore, an animal model
of joint laxity has been created, providing a critical tool for
the development of therapeutic interventions for EDS pa-
tients, as well as a larger group of non-EDS patients with joint
laxity. Model availability provides a unique opportunity to
evaluate a host of potential therapeutic agents, such as matrix
metalloproteinase inhibitors like doxycycline,44,45 or agents
that have been tried in attempts to control metastatic cancer
but failed because of patients developing the complication of
dose-dependent, reversible joint stiffness.46,47 In summary,
the Col5a1Dten/Dten mouse model is a model for the EDS and
hypermobile joint phenotype and can be used in future pre-
clinical studies of injury, as well as clinical interventions for
treatment of EDS and patients with hypermobile joints.
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